Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603967 · ClinicalTrials.gov registry record · NA
Effect of Aromatase Inhibitors on Bones and Genes
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT00603967 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 151 participants.
The verdict
NCT00603967, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The primary objective of this 2-year pilot project is to test the hypothesis that skeletal response to aromatase inhibitors is determined by polymorphisms of the CYP19 gene.
Interventions
- PROCEDURE Blood draw
- BEHAVIORAL Questionnaire
- PROCEDURE Dual x-ray absorptiometry (DXA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603967
The ClinicalTrials.gov registry entry for NCT00603967 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT00603967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00603967 about?
NCT00603967 is a clinical study titled "Effect of Aromatase Inhibitors on Bones and Genes". The primary objective of this 2-year pilot project is to test the hypothesis that skeletal response to aromatase inhibitors is determined by polymorphisms of the CYP19 gene.
What is the current status of trial NCT00603967?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2006-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00603967?
The interventions under investigation include: Blood draw (PROCEDURE), Questionnaire (BEHAVIORAL), Dual x-ray absorptiometry (DXA) (PROCEDURE).
Who is sponsoring clinical trial NCT00603967?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.